S tarting in November, the Hong Kong government plans to provide influenza vaccines to high-risk groups such as health-care workers, the elderly, and the disabled.
Speaking at a media briefing last week, Hong Kong's new Director of Health, Lam Ping-yan, said that influenza jabs would be given to all health-care workers and to about 59 000 elderly and 10 000 disabled people. He explained the reasoning behind this initiative: "Hopefully, if SARS [severe acute respiratory syndrome] actually comes back we will be able to distinguish between SARS and influenza because of the widespread vaccine programme."
As the SARS outbreak now appears to be drawing to a close, public-health officials are focusing on potential problems that may arise during the next flu season, when influenza is likely to raise suspicion of SARS. Due to possible confusion, WHO recommends that health-care workers in all countries be immunised against influenza (www.who.int/csr/don/2003_ 07_03/en/). Typically, during seasonal epidemics, the influenza virus can infect 10-20% of the total global population, which could result in more than 3 million cases of severe illness, with up to half a million deaths. Health-care systems confronted with these numbers of influenza cases that could also be SARS cases would be completely overburdened and unable to undertake the required isolation, contact tracing, and quarantine of suspected SARS patients.
But is it enough to immunise only health-care workers and other vulnerable populations? Some experts argue that compulsory flu immunisation for the majority of citizens may be more appropriate than just targeting high-risk groups. Commenting on the possibility of mass vaccination campaigns, Annelies Wilder-Smith (Tan Tock Seng Hospital, Singapore), told The Lancet that "broad coverage is needed; you want to keep all influenza cases to a minimum to reduce differential SARS diagnoses".
Flu vaccination as a public health preventive measure may be applicable in SARS risk areas globally, but particularly in regions designated "potential zones of re-emergence of SARS" and "nodal areas", as defined recently in a WHO document on the management of SARS in the post-outbreak period (www.who.int/csr/sars/ postoutbreak/en).
Influenza may resemble SARS, and pneumonia can be a feature of both diseases, which have highest mortality rates in people aged 65 years and over, and in those with comorbid conditions. To date, no simple diagnostic test is available to rule out SARS early in the course of the illness.
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Influenza vaccine enlisted to prevent SARS confusion
Many more eye specialists needed in Africa A frica, which is home to most of the world's estimated 45 million blind people, could reduce its prevalence of eye diseases if more people had access to eye specialists, according to the 31st Annual Scientific Conference of the Ophthalmological Society of East Africa in Kenya. Although WHO recommends an eye specialist for every 250 000 people, the ratios are as low as 1:1 million in Africa. Kenya alone has only 58 ophthalmologists for about 224 000 blind and 672 000 low-vision citizens, many of whom have preventable or treatable conditions like cataract, glaucoma, and trachoma. And most of its ophthalmologists are based in the capital city, Nairobi, while only 11 work in public hospitals.
Although WHO says considerable progress has been made in combating onchocerciasis, the world's second leading cause of blindness, present in 34 African countries, much more remains to be done.
Kenya's health minister, Charity Ngilu, challenged specialists from the East African region to address this situation in part by developing a regional centre to assist in the purchase, distribution, and maintenance of ophthalmic equipment. Such a move would solve the current problem of expensive equipment becoming obsolete due to lack of maintenance. And Dunera Ilako, who chairs the East African society, announced that plans by the organisation to start an ophthalmological college in collaboration with Vision 2020 "are at an advanced stage".
A recent study by Sight Savers International and Vision 2020, The magnitude and cost of global blindness: an increasing problem that can be alleviated, predicted that the poorest countries could potentially achieve a US$300 billion boost in economic productivity over 20 years if appropriate measures were adopted.
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